null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-Mouse CD115 (CSF-1R) In Vivo Antibody - Ultra Low Endotoxin (IVMB0002)

SKU IVMB0002
Antibody Type Functional-Grade In Vivo Antibody
Applications In Vivo, Blocking, CyTOF, Depletion, FA, FC
Clone AFS98
Protein CD115
Isotype Rat IgG2a kappa
Reactivity Mouse
Research Area Innate Lymphoid Cell Depletion, Macrophage Cell Depletion, Cytokines, Chemokines & Receptors
Endotoxin Level Ultra Low Endotoxin
Host Species Rat
Target / Synonyms::Macrophage Colony Stimulating Factor Receptor · M-CSFR · CSF-R1 · C-fms · CSF-1R
€359 - €4,859
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altTechnical Datasheet

Anti-Mouse CD115 (CSF-1R) In Vivo Antibody - Ultra Low Endotoxin

Introducing the Anti-Mouse CD115 (CSF-1R) In Vivo Antibody - Ultra Low Endotoxin from Assay Genie, a highly specific monoclonal antibody designed for in vivo applications. This antibody targets the CD115 (CSF-1R) protein, crucial for macrophage and monocyte signaling, making it ideal for research in immunology, oncology, and related fields. With a rat IgG2a isotype, it ensures ultra-low endotoxin levels (<0.1 EU/μg), perfect for a range of assays including ELISA, flow cytometry, and functional studies. Available in various sizes, it is formulated in phosphate-buffered saline for stability and efficacy.

Elevate your research with this reliable and versatile antibody. CD115, also known as colony-stimulating factor-1 receptor (CSF-1R), is a protein expressed on the surface of myeloid lineage cells, including monocytes, macrophages, and osteoclasts. It plays a pivotal role in the survival, proliferation, and differentiation of these cells by binding to its ligands, CSF-1 and IL-34, and triggering downstream signaling pathways. This makes CD115 a key player in immune regulation and a target of interest in various disease models.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose